| Ytd | -1.06% | |
| 1y | 5.73% |
| Open | 85.41 | Prev Close | 85.25 | Low | 85.41 | High | 87.62 | Mkt Cap | 5.21B |
| Vol | 480.79K | Avg Vol | 796.95K | EPS | 2.43 | P/E | 35.89 | Forward P/E | 18.91 |
| Beta | 0.51 | Short Ratio | 6.16 | Inst. Own | 107.68% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 10-29 | 50-d Avg | 87.96 | 200-d Avg | 76.70 | 1yr Est | 101.45 |
Oncology stocks are gaining relevance as cancer care evolves, with Pfizer, Merit Medical Systems and
SOUTH JORDAN, Utah, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a
Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either H
MMSI's broad product portfolio, global expansion and strategic M&A support growth, while tariffs and
Here, we highlight five medical supplies stocks, MCK, CAH, BDX, MMSI and PDEX, with strong potential
Needham analyst Mike Matson reiterates Merit Medical Systems (NASDAQ:MMSI) with a Buy and maintai
Merit Medical Systems (NASDAQ: MMSI - Get Free Report) and Bausch + Lomb (NYSE: BLCO - Get Free Repo
SOUTH JORDAN, Utah, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a
Jupiter Topco LLC bought a new position in shares of Merit Medical Systems, Inc. (NASDAQ: MMSI) duri
Hsbc Holdings PLC purchased a new stake in shares of Merit Medical Systems, Inc. (NASDAQ: MMSI) duri
MMSI's broad portfolio, R&D investments and WRAPSODY opportunity support growth, while tariffs, Chin
Freestone Grove Partners LP purchased a new position in Merit Medical Systems, Inc. (NASDAQ: MMSI) i
Oncology innovation is driving new treatment options, with Iovance, Merit Medical and Kura advancing
American Capital Management Inc. acquired a new stake in Merit Medical Systems, Inc. (NASDAQ: MMSI)
Merit Medical's growth case is strengthening as launches, acquisitions and therapeutic products broa
Merit Medical's 22.2% monthly rally gains support from stronger Q2 growth and a raised 2026 outlook,
Investors with an interest in Medical - Dental Supplies stocks have likely encountered both The Coop
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t
SOUTH JORDAN, Utah, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a
Merit Medical Systems (NASDAQ: MMSI) is focused on completing the objectives of its current long-ran
Merit Medical Systems NASDAQ: MMSI is focused on completing the objectives of its current long-range
Top analysts changed outlook on top names. Truist, Morgan Stanley, B of A Securities, HC Wainwright,
B of A Securities analyst Craig Bijou maintains Merit Medical Systems (NASDAQ:MMSI) with a Neutra
BTIG analyst Sam Eiber reiterates Merit Medical Systems (NASDAQ:MMSI) with a Buy and maintains $1
Canaccord Genuity analyst Jon Young maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and
JP Morgan analyst Robbie Marcus maintains Merit Medical Systems (NASDAQ:MMSI) with a Overweight a
Piper Sandler analyst Jason Bednar maintains Merit Medical Systems (NASDAQ:MMSI) with a Overweigh
Wells Fargo analyst Larry Biegelsen maintains Merit Medical Systems (NASDAQ:MMSI) with a Equal-We
Merit Medical Systems Inc (NASDAQ: MMSI) reported strong Q2 earnings, beating estimates with raised
Needham analyst Mike Matson maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and raises t
BTIG analyst Sam Eiber maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and raises the pr
Merit Medical Systems (NASDAQ:MMSI) raises FY2026 Adj EPS guidance from $4.01-$4.15 to $4.25-$4.35 v
Canaccord Genuity analyst Jon Young maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and
JP Morgan analyst Robbie Marcus maintains Merit Medical Systems (NASDAQ:MMSI) with a Overweight a
Wells Fargo analyst Larry Biegelsen maintains Merit Medical Systems (NASDAQ:MMSI) with a Equal-We
Needham analyst Mike Matson maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and lowers t
Merit Medical Systems (NASDAQ:MMSI) affirms FY2026 Adj EPS guidance from $4.01-$4.15 to $4.01-$4.15
Merit Medical Systems (NASDAQ:MMSI) reported quarterly earnings of $0.94 per share which beat the an
Barrington Research analyst Michael Petusky maintains Merit Medical Systems (NASDAQ:MMSI) with a
Piper Sandler analyst Jason Bednar maintains Merit Medical Systems (NASDAQ:MMSI) with a Overweigh
The FDA labels Merit Medical catheter recall as high risk after injuries tied to a defective introdu
https://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/dialysis-catheter-recall
Canaccord Genuity analyst Jon Young maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and
Merit Medical Systems, Inc. (NASDAQ:MMSI), a global leader of healthcare technology, today announced
Wells Fargo analyst Larry Biegelsen downgrades Merit Medical Systems (NASDAQ:MMSI) from Overweigh
Barrington Research analyst Michael Petusky maintains Merit Medical Systems (NASDAQ:MMSI) with a
Needham analyst Mike Matson maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and lowers t